E. D. Pórtulas

Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behavior.

M. Bare, F. Navarro, M. V. Fraguell, 2016 .

Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.

G. Scagliotti, R. Govindan, J. Strausz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gastrointestinal stromal tumors: experience in 49 patients

C. P. Pijaume, Pere Rebasa Cladera, Analía Martín, 2006 .

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

N. Ribelles, J. García-Saenz, M. Gil-Gil, 2020, Clinical and Translational Oncology.